XML 50 R32.htm IDEA: XBRL DOCUMENT v3.25.1

Stockholders’ Equity (Tables)

12 Months Ended

Dec. 31, 2024

Stockholders’ Equity [Abstract]

Schedule of Status of Our Outstanding and Exercisable Warrants Related Transactions

As of December 31, 2024, the following table summarizes the status of our outstanding and exercisable warrants and related transactions since December 31, 2022 (in thousands, except weighted average exercise price and weighted average remaining contractual life data):

		Warrants outstanding and exercisable
		Warrants				Weighted Average Exercise Price				Aggregate Intrinsic Value				Weighted Average Remaining Contractual Life (in Years)
Balance, December 31, 2022			536			$	13.10				2,427				9.3
Exercised			(435	)			0.01				(2,720	)
Expired			(2	)			0.89
Balance, December 31, 2023			99				66.61				1,793				6.5
Expired			(1	)			281.50				—				—
Balance, December 31, 2024			98			$	63.33			$	—				5.6

Schedule of Status of Our Outstanding and Exercisable Options and Related Transactions

The following table summarizes the status of our outstanding and exercisable options and related transactions since December 31, 2022 (in thousands, except weighed average exercise price and weighted average remaining contractual life data):

		Outstanding																Exercisable
		Options Awards				Weighted Average Exercise Price				Aggregate Intrinsic Value				Weighted Average Remaining Contractual Life (in Years)				Options Awards				Weighted Average Exercise Price				Aggregate Intrinsic Value				Weighted Average Remaining Contractual Life (in Years)
As of December 31, 2022			172			$	228.28				—				3.6				170				229.43			$	—				3.6
Expired			(100	)			206.15				—				—				(98	)			—				—				—
As of December 31, 2023			72				258.55				—				3.0				72				258.46				—				3.0
Expired			(15	)			217				—				—				(15	)			—				—				—
As of December 31, 2024			57			$	270.33			$	—				2.8				57				270.20			$	—				2.8

Schedule of the Status of Our RSUs, and Related Transactions

The following table summarizes the status of our RSUs and related transactions (in thousands, except weighed average grant date fair value):

		RSUs awards outstanding
		RSUs				Weighted Average Grant Date Fair Value				Aggregate Intrinsic Value
Balance, as of December 31, 2022			57			$	14.57			$	318.63
Granted			163				4.82				—
Vested			(180	)			6.83				—
Balance, as of December 31, 2023			40				9.67				89.60
Vested			(38	)			9.11				—
Balance, as of December 31, 2024			2			$	21.78			$	1.49

Schedule of the Status of Our PSUs, and and Related Transactions

The following table summarizes the status of our PSUs and related transactions for each for the following years (in thousands, except weighed average grant date fair value):

		PSUs				Weighted Average Grant Date Fair Value				Aggregate Intrinsic Value
Unvested, as of December 31, 2022			19			$	52.15			$	107.55
Vested			(7	)			56.05				(10.72	)
Unvested, as of December 31, 2023			12				49.36				27.3
Vested			(7	)			60.50				16.16
Balance, as of December 31, 2024			5			$	34.50			$	4.47

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested performance-based units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration